FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
MedPage Today) — The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference counterpart, insulin aspart (Novolog…
MedPage Today) — The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday.
Like its reference counterpart, insulin aspart (Novolog…
Read More
About Author
